LianBio (LIANY)
OTCMKTS · Delayed Price · Currency is USD
0.1101
+0.0001 (0.09%)
May 21, 2026, 9:30 AM EST
LianBio Market Cap
LianBio has a market cap or net worth of $11.91 million as of May 21, 2026. Its market cap has decreased by -56.43% in one year.
Market Cap
11.91M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 11.91M, a decrease of -99.17%. That is a compound annual growth rate of -65.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 11.91M | 15.89% |
| Dec 31, 2025 | 10.28M | -64.15% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
| Nov 1, 2021 | 1.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 16.20M |
| Zenith Capital | 15.97M |
| HOOKIPA Pharma | 15.30M |
| Zeo ScientifiX | 14.85M |
| EOM Pharmaceuticals Holdings | 14.55M |
| Inhibitor Therapeutics | 13.81M |
| Finch Therapeutics Group | 11.96M |
| Curative Biotechnology | 11.51M |